Management of localized scleroderma.
Localized scleroderma denotes a spectrum of conditions characterized by circumscribed fibrotic areas involving different levels of the dermis, subcutis, and sometimes underlying soft tissue and bone. Although the clinical course of the disease is often benign, widespread lesions and disabling joint contractures may lead to significant complications. The pathogenesis of the different types of localized scleroderma is still unknown. Numerous therapeutic agents have been reported to be effective in this disease spectrum, but controlled studies are rare. The purpose of this review is to summarize previous experience and to discuss recent advances in the management of localized scleroderma.
Hunzelmann
N
N
Department of Dermatology, University of Cologne, Germany.
Scharffetter Kochanek
K
K
Hager
C
C
Krieg
T
T
D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy; D026741:Physical Therapy Modalities; D011379:Prognosis; D012594:Scleroderma, Localized / Q000503:physiopathology / Q000628:therapy*; D013514:Surgical Procedures, Operative; D014467:Ultraviolet Therapy